Leukapheresis Market by Type, Application, End-User

List of Tables

[190 Pages Report] The Leukapheresis Market size was estimated at USD 56.21 million in 2023 and expected to reach USD 61.62 million in 2024, at a CAGR 9.71% to reach USD 107.58 million by 2030.

The leukapheresis includes the products, devices, procedures, and services related to selectively removing white blood cells (leukocytes) from a patient's or donor's blood. It encompasses different types of leukapheresis procedures, such as autologous leukapheresis and allogeneic leukapheresis, which are applied across various therapeutic areas, including cancer treatment, hematopoietic stem cell transplantation (HSCT), chronic inflammatory diseases management, and immune system regulation. The expanding geriatric population increases the demand for leukapheresis treatments due to their increased susceptibility to age-related diseases. However, the high costs associated with devices and consumables necessary for leukapheresis pose significant barriers for patients and healthcare providers. Nevertheless, ongoing clinical trials exploring novel applications of leukapheresis-derived cells in areas including regenerative medicine present potential opportunities for the leukapheresis market.

KEY MARKET STATISTICS
Base Year [2023]	USD 56.21 million
Estimated Year [2024]	USD 61.62 million
Forecast Year [2030]	USD 107.58 million
CAGR (%)	9.71%

Type: Increasing use of leukapheresis devices for efficient separation of white blood cells

Leukapheresis devices are specialized equipment used to separate white blood cells from the blood of donors or patients for various medical applications such as cancer research, cell therapy development, or clinical transfusions. These devices are designed to ensure high-quality cell separation with minimal damage to the collected cells. The centrifugal leukapheresis devices use the principles of centrifugation to separate white blood cells based on their density. Membrane separators use porous membranes to separate leukocytes from other blood components based on their size. Leukapheresis disposables are single-use, sterile components used in the leukapheresis procedure to maintain aseptic conditions during cell collection and separation. These include apheresis kits, tubing sets, filters, and collection bags.

Application: Rising application of leukapheresis in therapeutics for improved patient outcome

In research applications, leukapheresis facilitates studying blood cancer types, stem cell research, and immunology by isolating white blood cells for high-quality sample analysis. The increasing use of leukapheresis in research applications arises primarily due to its ability to provide pure and concentrated samples that can improve experimental outcomes and facilitate accurate results. Therapeutically, leukapheresis has significant use in various medical procedures, including hematopoietic stem cell transplantation (HSCT), CAR-T cell therapy, transplantation medicine, and autoimmune disease management. Therapeutic applications provide clinical benefits such as reduced disease severity and improved patient outcomes by removing excess WBCs or facilitating targeted cellular therapies.

End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers

Academic and research Institutes focus on investigating the role of leukocytes in various diseases and developing new therapeutic strategies. Blood component providers and blood centers require effective leukapheresis devices to separate specific blood components needed for transfusions or therapeutic purposes. Contract Research Organizations (CROs) require leukapheresis products and services to support clinical trials and drug development processes on behalf of pharmaceutical and biotechnology companies. Hospitals and transfusion centers need leukapheresis devices to treat patients with leukemia or other hematological disorders through therapeutic leukocyte reduction. Pharmaceutical and biotechnology companies invest in advanced leukapheresis devices to support their research and development of new drugs targeting various diseases or conditions related to the immune system.

Regional Insights

The leukapheresis market is evolving in the Americas with robust healthcare infrastructure, increasing prevalence of leukemia, and adoption of advanced technologies. The European Union (EU) has shown a growing demand for leukapheresis products due to rising incidences of blood disorders. In the EMEA region, increased awareness about leukemia treatment options and improved healthcare infrastructure drive demand for leukapheresis products. The Asia Pacific region represents significant growth in the leukapheresis market due to increased healthcare expenditure, growing awareness of blood disorders, and advancements in healthcare technology. Besides, advancements in leukapheresis devices are anticipated to improve treatment outcomes and encourage their deployment across end-use sectors globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Leukapheresis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Leukapheresis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Leukapheresis Market, highlighting leading vendors and their innovative profiles. These include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..

Market Segmentation & Coverage

This research report categorizes the Leukapheresis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Leukapheresis Devices
  - Centrifugal Devices
  - Membrane Separators

Leukapheresis Disposables

Application
- Research Applications
- Therapeutic Applications

End-User
- Academic & Research Institutes
- Blood Component Providers & Blood Centers
- Contract Research Organizations
- Hospitals & Transfusion Centers
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Leukapheresis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Leukapheresis Market?

3. What are the technology trends and regulatory frameworks in the Leukapheresis Market?

4. What is the market share of the leading vendors in the Leukapheresis Market?

5. Which modes and strategic moves are suitable for entering the Leukapheresis Market?

Product Code: MRR-FD3F12D52871

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing application in cancer therapy
  - 5.1.1.2. Demand for leukapheresis in clinical research
  - 5.1.1.3. Growth in initiatives for blood donations
- 5.1.2. Restraints
  - 5.1.2.1. High cost of procedure
- 5.1.3. Opportunities
  - 5.1.3.1. Focus and investment in R&D activities
  - 5.1.3.2. Leukapheresis for CAR or Adoptive Cell Therapy
- 5.1.4. Challenges
  - 5.1.4.1. Potential issues related to leukapheresis including discomfort, redness, and bruising
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing use of leukapheresis devices for efficient separation of white blood cells
- 5.2.2. Application: Rising application of leukapheresis in therapeutics for improved patient outcome
- 5.2.3. End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Leukapheresis Market, by Type

6.1. Introduction
6.2. Leukapheresis Devices
6.3. Leukapheresis Disposables

7. Leukapheresis Market, by Application

7.1. Introduction
7.2. Research Applications
7.3. Therapeutic Applications

8. Leukapheresis Market, by End-User

8.1. Introduction
8.2. Academic & Research Institutes
8.3. Blood Component Providers & Blood Centers
8.4. Contract Research Organizations
8.5. Hospitals & Transfusion Centers
8.6. Pharmaceutical & Biotechnology Companies

9. Americas Leukapheresis Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Leukapheresis Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Leukapheresis Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. SCTbio Partners With Cyto-Care To Improve Cell Therapy Cryopreservation
- 12.3.2. Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines
- 12.3.3. Fresenius Kabi Launches Single-Needle Option for the Amicus Extracorporeal Photopheresis Protocol
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio